{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:30:31Z","timestamp":1793323831272,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110361","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:10:59Z","timestamp":1786342259000},"page":"110361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recent developments in donepezil-based hybrid molecules as multi-target therapeutics for Alzheimer's disease: A paradigm shift beyond symptomatic treatment"],"prefix":"10.1016","volume":"181","author":[{"given":"Nitin","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izhar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra Kumar","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.31887\/DCNS.2003.5.1\/hhippius","article-title":"The discovery of Alzheimer\u2019s disease","volume":"5","author":"Hippius","year":"2003","journal-title":"Dialogues Clin. Neurosci."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110361_bb0010","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1021\/acschemneuro.3c00393","article-title":"Pathogenesis of Alzheimer\u2019s disease and diversity of 1, 2, 3-triazole scaffold in drug development: design strategies, structural insights, and therapeutic potential","volume":"14","author":"Singh","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110361_bb0020","doi-asserted-by":"crossref","first-page":"14794","DOI":"10.3390\/ijms241914794","article-title":"Amyloid precursor protein and Alzheimer\u2019s disease","volume":"24","author":"Orobets","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110361_bb0025","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/med.21719","article-title":"A multitude of signaling pathways associated with Alzheimer\u2019s disease and their roles in AD pathogenesis and therapy","volume":"41","author":"Gadhave","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110361_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13231","article-title":"Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer\u2019s disease and frontotemporal dementia","volume":"34","author":"McInvale","year":"2024","journal-title":"Brain Pathol."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110361_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13113098","article-title":"Novel therapeutic strategies in Alzheimer's disease: pitfalls and challenges of anti-amyloid therapies and beyond","volume":"13","author":"Tondo","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bioorg.2026.110361_bb0040","article-title":"Novel small molecule-based acetylcholinesterase (AChE) inhibitors: from biological perspective to recent developments","volume":"12","author":"Sobha","year":"2024","journal-title":"Eur. J. Med. Chem. Reports"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7252882","article-title":"Tacrine derivatives in neurological disorders: focus on molecular mechanisms and neurotherapeutic potential","volume":"2022","author":"Mitra","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bioorg.2026.110361_bb0050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110361_bb0055","article-title":"Advancing care in Alzheimer's disease: current treatments and their impact on quality of life","volume":"17","author":"Yashaeva","year":"2025","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110361_bb0060","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3390\/life14121555","article-title":"Therapeutic options in Alzheimer's disease: from classic acetylcholinesterase inhibitors to multi-target drugs with pleiotropic activity","volume":"14","author":"Cacabelos","year":"2024","journal-title":"Life"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110361_bb0065","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3390\/antiox14121426","article-title":"Antioxidant natural compounds integrated with targeted protein degradation: a multi-modal strategy for Alzheimer\u2019s disease therapy","volume":"14","author":"Singh","year":"2025","journal-title":"Antioxidants"},{"issue":"49","key":"10.1016\/j.bioorg.2026.110361_bb0070","doi-asserted-by":"crossref","first-page":"30781","DOI":"10.1039\/D1RA03718H","article-title":"The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer\u2019s agents: highlights from 2010 to 2020","volume":"11","author":"Kareem","year":"2021","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110361_bb0075","first-page":"311","article-title":"Recent modifications of anti-dementia agents focusing on tacrine and\/or donepezil analogs","volume":"19","author":"Mohamed","year":"2023","journal-title":"Med. Chem. (Los. Angeles)"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110361_bb0080","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.3390\/molecules29225314","article-title":"New insights into the development of donepezil-based hybrid and natural molecules as multi-target drug agents for Alzheimer\u2019s disease treatment","volume":"29","author":"Angelova","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110361_bb0085","doi-asserted-by":"crossref","first-page":"102849","DOI":"10.1016\/j.mtbio.2026.102849","article-title":"Research progress of blood-brain barrier penetrating and brain diseases therapy by natural biopolymer-based nanomedicine delivery systems","volume":"37","author":"Qin","year":"2026","journal-title":"Mater. Today Bio."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110361_bb0090","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/ijms22031273","article-title":"The cholinergic system, the adrenergic system and the neuropathology of Alzheimer\u2019s disease","volume":"22","author":"Bekdash","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110361_bb0095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1474-4422(21)00377-X","article-title":"Cholinergic system changes in Parkinson\u2019s disease: emerging therapeutic approaches","volume":"21","author":"Bohnen","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2026.110361_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105393","article-title":"Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer\u2019s disease- evidence from an MRI-based meta-analysis","volume":"154","author":"Mieling","year":"2023","journal-title":"Neurosci. Biobehav. Rev"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110361_bb0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3233\/JAD-220766","article-title":"Loss of cholinergic receptor muscarinic 1 (CHRM1) protein in the Hippocampus and temporal cortex of a subset of individuals with Alzheimer\u2019s disease, Parkinson\u2019s disease, or frontotemporal dementia: implications for patient survival","volume":"90","author":"Sabbir","year":"2022","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110361_bb0110","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s12035-024-04333-y","article-title":"An expanded narrative review of neurotransmitters on Alzheimer's disease: the role of therapeutic interventions on neurotransmission","volume":"62","author":"Akyuz","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bioorg.2026.110361_bb0115","doi-asserted-by":"crossref","DOI":"10.37349\/ent.2026.1004136","article-title":"Neuroprotection beyond neurons: integrated biomarker-based and astroglia-or microglia-targeted approaches to combat neurodegenerative diseases","volume":"6","author":"Volont\u00e9","year":"2026","journal-title":"Explor. Neuroprotective Ther."},{"issue":"24","key":"10.1016\/j.bioorg.2026.110361_bb0120","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.3390\/ijms262411843","article-title":"Neurovascular dysfunction and glymphatic impairment: an unexplored therapeutic frontier in neurodegeneration","volume":"26","author":"Mansour","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110361_bb0125","article-title":"Neurobiology of schizophrenia: a comprehensive review","volume":"14","author":"Luvsannyam","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","article-title":"The duality of amyloid-\u03b2: its role in normal and Alzheimer's disease states","volume":"17","author":"Azargoonjahromi","year":"2024","journal-title":"Mol. Brain"},{"issue":"19","key":"10.1016\/j.bioorg.2026.110361_bb0135","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1042\/BCJ20240056","article-title":"Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer\u2019s disease mutations","volume":"481","author":"Wang","year":"2024","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2026.110361_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00137","article-title":"Targeting amyloidogenic processing of APP in Alzheimer's disease","volume":"13","author":"Zhao","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110361_bb0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/molecules26020388","article-title":"Probing mechanisms and therapeutic potential of $\u03b3$-secretase in Alzheimer\u2019s disease","volume":"26","author":"Wolfe","year":"2021","journal-title":"Molecules"},{"issue":"667","key":"10.1016\/j.bioorg.2026.110361_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn9380","article-title":"Synaptogenic effect of APP-Swedish mutation in familial Alzheimer\u2019s disease","volume":"14","author":"Zhou","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0155","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.18632\/aging.102677","article-title":"Down syndrome and Alzheimer\u2019s disease: common molecular traits beyond the amyloid precursor protein","volume":"12","author":"Gomez","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bioorg.2026.110361_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.733857","article-title":"Amyloid-\u03b2 and $\u03b1$-synuclein immunotherapy: from experimental studies to clinical trials","volume":"15","author":"Nimmo","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110361_bb0165","doi-asserted-by":"crossref","unstructured":"G. Plascencia-Villa, G. Perry, and A. G. MDPI, \u201cRoles of oxidative stress in synaptic dysfunction and neuronal cell death in Alzheimer's disease. Antioxidants 2023; 12: 1628,\u201d DOI https:\/\/doi.org\/10.3390\/antiox12081628, 2023.","DOI":"10.3390\/antiox12081628"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110361_bb0170","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamaneurol.2024.0991","article-title":"Downstream biomarker effects of gantenerumab or solanezumab in dominantly inherited alzheimer disease: the DIAN-TU-001 randomized clinical trial","volume":"81","author":"Wagemann","year":"2024","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110361_bb0175","doi-asserted-by":"crossref","first-page":"771","DOI":"10.14283\/jpad.2023.123","article-title":"Lecanemab clarity AD: quality-of-life results from a randomized, double-blind phase 3 trial in early Alzheimer\u2019s disease","volume":"10","author":"Cohen","year":"2023","journal-title":"J. Prev Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110361_bb0180","doi-asserted-by":"crossref","first-page":"25001","DOI":"10.1088\/2632-072X\/ac5f8d","article-title":"EEG functional connectivity and deep learning for automatic diagnosis of brain disorders: Alzheimer\u2019s disease and schizophrenia","volume":"3","author":"Alves","year":"2022","journal-title":"J. Phys. Complex."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110361_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010929","article-title":"Infectious origin of Alzheimer\u2019s disease: amyloid beta as a component of brain antimicrobial immunity","volume":"18","author":"Vojtechova","year":"2022","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-025-08186-8","article-title":"Amyloid-\u03b2 and tau in Alzheimer\u2019s disease: pathogenesis, mechanisms, and interplay","volume":"17","author":"bdulkhaliq","year":"2026","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110361_bb0195","doi-asserted-by":"crossref","first-page":"2200138","DOI":"10.1002\/bies.202200138","article-title":"Tau, microtubule dynamics, and axonal transport: new paradigms for neurodegenerative disease","volume":"45","author":"Cario","year":"2023","journal-title":"Bioessays"},{"issue":"21","key":"10.1016\/j.bioorg.2026.110361_bb0200","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0205","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-025-02179-x","article-title":"Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery","volume":"10","author":"Wu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110361_bb0210","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110361_bb0215","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s10072-020-04901-9","article-title":"New MAPT variant in a FTD patient with Alzheimer's disease phenotype at onset","volume":"42","author":"Caroppo","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.bioorg.2026.110361_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1459025","article-title":"The role of PI3K signaling pathway in Alzheimer's disease","volume":"16","author":"Pan","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110361_bb0225","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/antiox10091479","article-title":"Oxidative stress and beta amyloid in Alzheimer's disease. Which comes first: the chicken or the egg?","volume":"10","author":"Tamagno","year":"2021","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110361_bb0230","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/biomedicines9080918","article-title":"Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson's disease","volume":"9","author":"Kung","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110361_bb0235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3892\/ijmm.2025.5613","article-title":"Copper homeostasis and cuproptosis in Alzheimer\u2019s disease","volume":"56","author":"Cong","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0240","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41392-025-02439-w","article-title":"Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations","volume":"10","author":"Kuzu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.110361_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102713","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"107","author":"D\u2019Alessandro","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bioorg.2026.110361_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1484373","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: a key frontier for future targeted therapies","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0255","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110361_bb0260","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3233\/JAD-200473","article-title":"Alzheimer\u2019s disease: the link between amyloid-\u03b2 and neurovascular dysfunction","volume":"76","author":"Solis","year":"2020","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110361_bb0265","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7555\/JBR.36.20220105","article-title":"Dysfunction of the neurovascular unit in brain aging","volume":"37","author":"Liu","year":"2023","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.bioorg.2026.110361_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2023.107213","article-title":"Amyloid-\u03b2: a potential mediator of aging-related vascular pathologies","volume":"152","author":"Khan","year":"2023","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110361_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102578","article-title":"Non-canonical pathways associated to amyloid beta and tau protein dyshomeostasis in Alzheimer\u2019s disease: a narrative review","volume":"102","author":"Maggiore","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110361_bb0280","doi-asserted-by":"crossref","first-page":"9245","DOI":"10.3390\/ijms26189245","article-title":"Pathological calcium signaling in traumatic brain injury and Alzheimer\u2019s disease: from acute neuronal injury to chronic neurodegeneration","volume":"26","author":"Neuschmid","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110361_bb0285","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/acschemneuro.0c00811","article-title":"A\u03b2 oligomers dysregulate calcium homeostasis by mechanosensitive activation of AMPA and NMDA receptors","volume":"12","author":"Fani","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0290","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0295","doi-asserted-by":"crossref","first-page":"12350","DOI":"10.1038\/s41598-021-91726-x","article-title":"Dendritic spines are lost in clusters in Alzheimer\u2019s disease","volume":"11","author":"Mijalkov","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110361_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106301","article-title":"The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators","volume":"131","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110361_bb0305","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.3390\/molecules27165066","article-title":"A\u03b2 and tau interact with metal ions, lipid membranes and peptide-based amyloid inhibitors: are these common features relevant in Alzheimer\u2019s disease?","volume":"27","author":"Di Natale","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110361_bb0310","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5414\/TE500056","article-title":"Metal chelators as part of a strategy for the treatment of neurodegenerative diseases","volume":"40","author":"Leal","year":"2023","journal-title":"Trace Elem. Electrolytes"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110361_bb0315","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.14336\/AD.2022.0412","article-title":"Amyloid cascade hypothesis for the treatment of Alzheimer's disease: progress and challenges","volume":"13","author":"Wu","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.bioorg.2026.110361_bb0320","doi-asserted-by":"crossref","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110361_bb0325","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/biom10101439","article-title":"Microglia in Alzheimer\u2019s disease in the context of tau pathology","volume":"10","author":"Perea","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100013","article-title":"Microglial activation states and their implications for Alzheimer\u2019s disease","volume":"12","author":"Valiukas","year":"2025","journal-title":"J. Prev Alzheimers Dis."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110361_bb0335","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/brainsci14111101","article-title":"Alzheimer\u2019s disease, obesity, and type 2 diabetes: focus on common neuroglial dysfunctions (critical review and new data on human brain and models)","volume":"14","author":"Toledano","year":"2024","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11011-024-01472-y","article-title":"Research progress on the association of insulin resistance with type 2 diabetes mellitus and Alzheimer's disease","volume":"40","author":"Zheng","year":"2024","journal-title":"Metab. Brain Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110361_bb0345","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.3390\/ijms24054354","article-title":"Metabolic syndrome as a risk factor for Alzheimer\u2019s disease: a focus on insulin resistance","volume":"24","author":"Ezkurdia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0350","doi-asserted-by":"crossref","DOI":"10.1038\/s41514-021-00064-9","article-title":"Abnormal brain cholesterol homeostasis in Alzheimer\u2019s disease\u2014a targeted metabolomic and transcriptomic study","volume":"7","author":"Varma","year":"2021","journal-title":"npj Aging Mech. Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110361_bb0355","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bmc.2010.01.071","article-title":"Targeting Alzheimer\u2019s disease: novel indanone hybrids bearing a pharmacophoric fragment of AP2238","volume":"18","author":"Rizzo","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110361_bb0360","article-title":"A novel multifunctional 5,6-dimethoxy-indanone-chalcone-carbamate hybrids alleviates cognitive decline in Alzheimer\u2019s disease by dual inhibition of acetylcholinesterase and inflammation","volume":"14","author":"Liu","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110361_bb0365","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/acschemneuro.1c00535","article-title":"Donepezil-inspired multitargeting indanone derivatives as effective anti-Alzheimer\u2019s agents","volume":"13","author":"Singh","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110361_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107229","article-title":"Hybrid pharmacophore design and synthesis of donepezil-inspired aurone derivative salts as multifunctional acetylcholinesterase inhibitors","volume":"145","author":"Funahashi","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110361_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000453","article-title":"Hybridization-based design of novel anticholinesterase indanone--carbamates for Alzheimer\u2019s disease: synthesis, biological evaluation, and docking studies","volume":"354","author":"Shahrivar-Gargari","year":"2021","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2026.110361_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129938","article-title":"Synthesis and evaluation of lipoic acid--donepezil hybrids for Alzheimer\u2019s disease using a straightforward strategy","volume":"112","author":"Luzet","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0385","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1134\/S0006297923010054","article-title":"A novel donepezil\u2013caffeic acid hybrid: synthesis, biological evaluation, and molecular docking studies","volume":"88","author":"K\u0131l\u0131\u00e7aslan","year":"2023","journal-title":"Biochemistry (Moscow)"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110361_bb0390","doi-asserted-by":"crossref","first-page":"216","DOI":"10.17776\/csj.1414168","article-title":"Donepezil-squaric acid hybrid: synthesis, characterization and investigation of anticholinesterase inhibitory, DNA binding and antioxidant properties","volume":"45","author":"K\u0131l\u0131\u00e7aslan","year":"2024","journal-title":"Cumhur. Sci. J."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/open.202500366","article-title":"Piperazine derivatives: a privileged scaffold in modern synthesis and medicinal chemistry","volume":"15","author":"Ten","year":"2026","journal-title":"ChemistryOpen"},{"issue":"29","key":"10.1016\/j.bioorg.2026.110361_bb0400","doi-asserted-by":"crossref","first-page":"38855","DOI":"10.1007\/s11356-021-13320-y","article-title":"Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders","volume":"28","author":"Mathew","year":"2021","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.bioorg.2026.110361_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114358","article-title":"Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer\u2019s disease","volume":"237","author":"Brunetti","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110361_bb0410","doi-asserted-by":"crossref","unstructured":"A. M. Soliman, H. A. A. Abd El-wahab, H. Akincioglu, \u0130. G\u00fcl\u00e7in, and F. A. Omar, \u201cPiperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: anticholinesterase activity, mechanistic aspect, and molecular modeling studies,\u201d Bioorg. Chem., vol. 142, no. 2023, 2024, doi:https:\/\/doi.org\/10.1016\/j.bioorg.2023.106916.","DOI":"10.1016\/j.bioorg.2023.106916"},{"key":"10.1016\/j.bioorg.2026.110361_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116463","article-title":"Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer\u2019s disease","volume":"272","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110361_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112282","article-title":"N-alkylpiperidine carbamates as potential anti-Alzheimer\u2019s agents","volume":"197","author":"Ko\u0161ak","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110361_bb0425","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/ddr.22064","article-title":"Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer\u2019s disease","volume":"84","author":"Eissa","year":"2023","journal-title":"Drug Dev. Res."},{"issue":"December 2023","key":"10.1016\/j.bioorg.2026.110361_bb0430","article-title":"Novel acetylcholinesterase inhibitors: synthesis, docking and inhibitory activity evaluation of 4-benzamido-N-(1-benzylpiperidin-4-yl) benzamide derivatives","volume":"7","author":"Mohammadi-Farani","year":"2024","journal-title":"Results Chem."},{"issue":"December 2022","key":"10.1016\/j.bioorg.2026.110361_bb0435","doi-asserted-by":"crossref","first-page":"117178","DOI":"10.1016\/j.bmc.2023.117178","article-title":"Design, synthesis, and biological evaluation of novel N-benzyl piperidine derivatives as potent HDAC\/AChE inhibitors for Alzheimer\u2019s disease","volume":"80","author":"Qin","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110361_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031867","article-title":"Protective effect of the novel melatonin analogue containing donepezil fragment on memory impairment via MT\/ERK\/CREB signaling in the Hippocampus in a rat model of pinealectomy and subsequent A\u03b21-42 infusion","volume":"25","author":"Tchekalarova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110361_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/ph16091194","article-title":"Design, synthesis, in silico studies and in vitro evaluation of new indole- and\/or donepezil-like hybrids as multitarget-directed agents for Alzheimer\u2019s disease","volume":"16","author":"Angelova","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"18","key":"10.1016\/j.bioorg.2026.110361_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200300","article-title":"A coumarin- donepezil hybrid as a blood- brain barrier permeable dual cholinesterase inhibitor: isolation, synthetic modifications, and biological evaluation of natural coumarins","volume":"17","author":"Sharma","year":"2022","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110361_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300693","article-title":"Design, synthesis, and evaluation of dual-target inhibitors for the treatment of Alzheimer\u2019s disease","volume":"357","author":"Zhai","year":"2024","journal-title":"Arch. Pharm. (Weinheim)."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110361_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25040985","article-title":"Design, synthesis, and in vitro evaluation of hydroxybenzimidazole-donepezil analogues as multitarget-directed ligands for the treatment of Alzheimer's disease","volume":"25","author":"Chaves","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110361_bb0465","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1039\/C9MD00441F","article-title":"Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer\u2019s disease","volume":"11","author":"Wang","year":"2020","journal-title":"RSC Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110361_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26061658","article-title":"Novel donepezil--arylsulfonamide hybrids as multitarget-directed ligands for potential treatment of Alzheimer\u2019s disease","volume":"26","author":"Queda","year":"2021","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110361_bb0475","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1007\/s11064-020-03148-2","article-title":"Cinnamoyl-n-acylhydrazone-donepezil hybrids: synthesis and evaluation of novel multifunctional ligands against neurodegenerative diseases","volume":"45","author":"Ortiz","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bioorg.2026.110361_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110227","article-title":"Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction","volume":"368","author":"Honorio","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110361_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26051303","article-title":"Claulansine F--donepezil hybrids as anti-Alzheimer's disease agents with cholinergic, free-radical scavenging, and neuroprotective activities","volume":"26","author":"Zang","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110361_bb0490","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/1567205016666190228122956","article-title":"Donepezil derivatives targeting amyloid-\u03b2 cascade in Alzheimer\u2019s disease","volume":"16","author":"Mezeiova","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bioorg.2026.110361_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104974","article-title":"Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer\u2019s disease treatment","volume":"112","author":"Makhaeva","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110361_bb0500","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00044-022-02886-y","article-title":"Discovery of novel donepezil-M30D hybrids with neuroprotective properties for Alzheimer\u2019s disease treatment","volume":"31","author":"Yepes","year":"2022","journal-title":"Med. Chem. Res."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110361_bb0505","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300575","article-title":"Novel multifunctional tacrine--donepezil hybrids against Alzheimer\u2019s disease: design synthesis and bioactivity studies","volume":"357","author":"Bayraktar","year":"2024","journal-title":"Arch. Pharm. (Weinheim)."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110361_bb0510","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1021\/acs.jcim.0c00496","article-title":"Discovery of a new donepezil-like acetylcholinesterase inhibitor for targeting Alzheimer\u2019s disease: computational studies with biological validation","volume":"60","author":"Akhoon","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0515","first-page":"1","article-title":"Investigation, scaffold hopping of novel donepezil-based compounds as anti-Alzheimer\u2019s agents: synthesis, in silico and pharmacological evaluations","volume":"14","author":"Gupta","year":"2024","journal-title":"Sci. Rep."},{"issue":"32","key":"10.1016\/j.bioorg.2026.110361_bb0520","doi-asserted-by":"crossref","first-page":"29631","DOI":"10.1039\/D6RA03862J","article-title":"Bridging the gap in Alzheimer\u2019s therapy: strategic design and SAR evolution of coumarin-based hybrids as potent MTDLs","volume":"16","author":"El-Mokaddem","year":"2026","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110361_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102033","article-title":"The neurobiology and therapeutic potential of multi-targeting \u03b2-secretase, glycogen synthase kinase 3\u03b2 and acetylcholinesterase in Alzheimer\u2019s disease","volume":"90","author":"Fronza","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bioorg.2026.110361_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00265","article-title":"Drug design for CNS diseases: polypharmacological profiling of compounds using cheminformatic, 3D-QSAR and virtual screening methodologies","volume":"10","author":"Nikolic","year":"2016","journal-title":"Front. Neurosci."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110361_bb0535","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1021\/acs.jmedchem.9b00017","article-title":"Rational design of multitarget-directed ligands: strategies and emerging paradigms","volume":"62","author":"Zhou","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110361_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70131","article-title":"Multi-target drug design in Alzheimer\u2019s disease treatment: emerging technologies, advantages, challenges, and limitations","volume":"13","author":"Hossain","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110361_bb0545","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110361_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083905","article-title":"Recent advances in drug development for Alzheimer\u2019s disease: a comprehensive review","volume":"26","author":"Xing","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110361_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178192","article-title":"Design, synthesis, and preclinical evaluation of novel 1-benzylpiperidine derivatives as multitarget agents against Alzheimer\u2019s disease","volume":"1006","author":"Ramachandran","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110361_bb0560","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1021\/acsomega.3c10276","article-title":"Structure-guided design, synthesis, and biological evaluation of peripheral anionic site selective and brain permeable novel oxadiazole-piperazine conjugates against Alzheimer\u2019s disease with antioxidant potential","volume":"9","author":"Singh","year":"2024","journal-title":"ACS Omega"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:13:11Z","timestamp":1791407591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":112,"alternative-id":["S0045206826008977"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110361","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent developments in donepezil-based hybrid molecules as multi-target therapeutics for Alzheimer's disease: A paradigm shift beyond symptomatic treatment","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110361"}}